Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind Phase II trial of RFUS-188 injection for postoperative analgesia after abdominal surgery
CTR20263015Phase 2Active
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RFUS-188 in acute postoperative pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Aug 2026; status: active.
02
Drugs
RFUS-188
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on CTR20263015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263015.